Effects of Chlorhexidine and Povidone-Iodine on the SARS-CoV-2 Load: A Systematic Review and Meta-analysis

Abstract

The efficacy of mouthwash for reducing the viral load in patients with the novel coronavirus disease 2019 (COVID-19) remains unclear. This systematic review and meta-analysis comprehensively examined the effects of chlorhexidine (CHX) and povidone-iodine (PVP-I) on the viral load in patients with COVID-19. We performed methodological analysis, systematic review, and meta-analysis of included studies using the Comprehensive Meta-analysis Software. PubMed, EMBASE, Cochrane Library, and ProQuest were searched from December 1, 2019, to December 2, 2021. In total, we included 10 studies of 1,339 patients with COVID-19. Compared with the control group, both CHX and PVP-I significantly reduced the number of negative reverse-transcription polymerase chain reaction (RT-PCR) results (p<0.001) among COVID-19 patients. The CHX and PVP-I were effective on reducing the number of negative RT-PCR results in COVID-19 patients. Additional studies using adequate randomization methods and larger samples are warned.

Keywords

mouthwash - oral health - viral load - cycle threshold - infectious disease

Publikationsverlauf

Artikel online veröffentlicht:
08. September 2022

• References

• 1 Zhu N, Zhang D, Wang W. et al; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
• 2 World Health Organization. Novel coronavirus (2019-nCoV): situation report, 3. Accessed November 10, 2020 at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200123-sitrep-3-2019-ncov.pdf
• 3 Huang Y. The SARS epidemic and its aftermath in China: a political perspective. In: Institute of Medicine (U.S.) Forum on Microbial Threats. Knobler S, Mahmoud A, Lemon S. et al., editors. Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary. Washington, DC: National Academies Press (U.S.); 2004
• 4 Xu RH, He JF, Evans MR. et al. Epidemiologic clues to SARS origin in China. Emerg Infect Dis 2004; 10 (06) 1030-1037
• 5 Zhong NS, Zheng BJ, Li YM. et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 2003; 362 (9393): 1353-1358
• 6 Lai CC, Liu YH, Wang CY. et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect 2020; 53 (03) 404-412
• 7 Petersen E, Koopmans M, Go U. et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis 2020; 20 (09) e238-e244
• 8 Alharbi A, Alharbi S, Alqaidi S. Guidelines for dental care provision during the COVID-19 pandemic. Saudi Dent J 2020; 32 (04) 181-186
• 9 Wang C, Miao L, Wang Z, Xiong Y, Jiao Y, Liu H. Emergency management in a dental clinic during the coronavirus disease 2019 (COVID-19) epidemic in Beijing. Int Dent J 2021; 71 (01) 32-39
• 10 Luo L, Liu D, Liao X-l. et al. Modes of contact and risk of transmission in COVID-19 among close contacts. medRxiv 2020;
• 11 Farook FF, Mohamed Nuzaim MN, Taha Ababneh K, Alshammari A, Alkadi L. COVID-19 pandemic: oral health challenges and recommendations. Eur J Dent 2020; 14 (S 01): S165-S170
• 12 Dennison DK, Meredith GM, Shillitoe EJ, Caffesse RG. The antiviral spectrum of Listerine antiseptic. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79 (04) 442-448
• 13 Eggers M, Koburger-Janssen T, Ward LS, Newby C, Müller S. Bactericidal and virucidal activity of povidone-iodine and chlorhexidine gluconate cleansers in an in vivo hand hygiene clinical simulation study. Infect Dis Ther 2018; 7 (02) 235-247
• 14 Carrouel F, Conte MP, Fisher J. et al. COVID-19: A recommendation to examine the effect of mouthrinses with β-Cyclodextrin combined with Citrox in preventing infection and progression. J Clin Med 2020; 9 (04) 1126
• 15 Imran E, Khurshid Z, M. Al Qadhi AA, A. Al-Quraini AA, Tariq K. Preprocedural use of povidone-iodine mouthwash during dental procedures in the COVID-19 pandemic. Eur J Dent 2020; 14 (S 01): S182-S184
• 16 Koletsi D, Belibasakis GN, Eliades T. Interventions to reduce aerosolized microbes in dental practice: a systematic review with network meta-analysis of randomized controlled trials. J Dent Res 2020; 99 (11) 1228-1238
• 17 Cavalcante-Leão BL, de Araujo CM, Basso IB. et al. Is there scientific evidence of the mouthwashes effectiveness in reducing viral load in Covid-19? A systematic review. J Clin Exp Dent 2021; 13 (02) e179-e189
• 18 Ortega KL, Rech BO, El Haje GLC, Gallo CB, Pérez-Sayáns M, Braz-Silva PH. Do hydrogen peroxide mouthwashes have a virucidal effect? A systematic review. J Hosp Infect 2020; 106 (04) 657-662
• 19 Vásquez AH, Pulache AB, Comandé D, Azañedo D. Mouth-rinses and SARS-CoV-2 viral load in saliva: a living systematic review. medRxiv 2021;
• 20 Mateos-Moreno MV, Mira A, Ausina-Márquez V, Ferrer MD. Oral antiseptics against coronavirus: in-vitro and clinical evidence. J Hosp Infect 2021; 113: 30-43
• 21 Moosavi MS, Aminishakib P, Ansari M. Antiviral mouthwashes: possible benefit for COVID-19 with evidence-based approach. J Oral Microbiol 2020; 12 (01) 1794363
• 22 Maraolo AE. Una bussola per le revisioni sistematiche: la versione italiana della nuova edizione del PRISMA statement. BMJ 2021; 372: 71
• 23 Etievant S, Bal A, Escuret V. et al. Performance assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratories. J Clin Med 2020; 9 (06) 1871
• 24 Higgins JP, Thomas J, Chandler J. et al. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.0. Hoboken, NJ: John Wiley & Sons; 2019
• 25 Higgins JP. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1. Accessed June 7, 2022 at: https://training.cochrane.org/handbook/archive/v5.0.0/
• 26 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7 (03) 177-188
• 27 Cohen J. Statistical power analysis for the behavioral sciences. Hillsdle. In: Erlbaum. Conner, BE. The Box in the Barn. New York, NY: Lawrence Erlbaum Associates; 1988
• 28 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327 (7414): 557-560
• 29 Avhad S, Bhanushali M, Sachdev S, Save S, Kalra D, Kamala D. Comparison of effectiveness of chlorine dioxide mouthwash and chlorhexidine gluconate mouthwash in reduction of oral viral load in patients with COVID-19. Indian J Public Health Res Dev 2020; 11 (11) 27-32
• 30 Choudhury MIM, Shabnam N, Ahsan T, Kabir MS, Khan RM, Ahsan SA. Effect of 1% povidone iodine mouthwash/gargle, nasal and eye drop in COVID-19 patient. Biores Commun 2021; 7 (01) 919-923
• 31 Costa DD, Brites C, Vaz SN, de Santana DS, Dos Santos JN, Cury PR. Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial. Oral Dis 2022; 28 (Suppl 2): 2500-2508
• 32 Eduardo FP, Corrêa L, Heller D. et al. Salivary SARS-CoV-2 load reduction with mouthwash use: a randomized pilot clinical trial. Heliyon 2021; 7 (06) e07346
• 33 Elzein R, Abdel-Sater F, Fakhreddine S. et al. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial. J Evid Based Dent Pract 2021; 21 (03) 101584
• 34 Guenezan J, Garcia M, Strasters D. et al. Povidone iodine mouthwash, gargle, and nasal spray to reduce nasopharyngeal viral load in patients with COVID-19: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2021; 147 (04) 400-401
• 35 Huang YH, Huang JT. Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients. J Med Virol 2021; 93 (07) 4370-4373
• 36 Mohamed NA, Baharom N, Sulaiman WSW. et al. Early viral Clearance among COVID-19 patients when gargling with povidone-iodine and essential oils–a clinical trial. medRxiv 2020;
• 37 Mukhtar K, Qassim S, Al Qahtani SA. et al. A randomized trial on the regular use of potent mouthwash in COVID-19 treatment. medRxiv 2021;
• 38 Seneviratne CJ, Balan P, Ko KKK. et al. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore. Infection 2021; 49 (02) 305-311
• 39 Stawarz-Janeczek M, Kryczyk-Poprawa A, Muszyńska B, Opoka W, Pytko-Polończyk J. Disinfectants used in stomatology and SARS-CoV-2 infection. Eur J Dent 2021; 15 (02) 388-400
• 40 Vergara-Buenaventura A, Castro-Ruiz C. Use of mouthwashes against COVID-19 in dentistry. Br J Oral Maxillofac Surg 2020; 58 (08) 924-927
• 41 Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008; 46 (02) 274-281
• 42 Vitkov L, Hermann A, Krautgartner WD. et al. Chlorhexidine-induced ultrastructural alterations in oral biofilm. Microsc Res Tech 2005; 68 (02) 85-89
• 43 da Costa LFNP, Amaral CDSF, Barbirato DDS, Leão ATT, Fogacci MF. Chlorhexidine mouthwash as an adjunct to mechanical therapy in chronic periodontitis: a meta-analysis. J Am Dent Assoc 2017; 148 (05) 308-318
• 44 Jain A, Grover V, Singh C. et al. Chlorhexidine: an effective anticovid mouth rinse. J Indian Soc Periodontol 2021; 25 (01) 86-88
• 45 Komine A, Yamaguchi E, Okamoto N, Yamamoto K. Virucidal activity of oral care products against SARS-CoV-2 in vitro . J Oral Maxillofac Surg Med Pathol 2021; 33 (04) 475-477
• 46 Slots J. Selection of antimicrobial agents in periodontal therapy. J Periodontal Res 2002; 37 (05) 389-398
• 47 James P, Worthington HV, Parnell C. et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev 2017; 3 (03) CD008676
• 48 Prathap S, Rajesh H, Boloor VA, Rao AS. Extrinsic stains and management: A new insight. J Acad Ind Res 2013; 1 (08) 435-442
• 49 Kouadio AA, Struillou X, Bories C, Bouler JM, Badran Z, Soueidan A. An in vitro analysis model for investigating the staining effect of various chlorhexidine-based mouthwashes. J Clin Exp Dent 2017; 9 (03) e410-e416